HIL interference was widespread among the 35 Abbott Alinity clinical chemistry assays that were examined in this investigation. An accessible way to determine the existence of hemolysis, icterus, and lipemia that could potentially alter the data produced by the 35 clinical chemistry assays is the automated HIL procedure using the Alinity c system. According to analytical and clinical relevance, clinical laboratories should set acceptance criteria for the HIL interference limits. Using the criteria used in this investigation, it was demonstrated that hemolysis interfered with 12 of the 35 assays that were examined. It is widely known that the release of intracellular components, such as hemoglobin from erythrocytes associated with hemolysis, can result in an increase in the plasma and serum concentrations of several analytes that are present in high concentrations within cells, such as AST, LDH, and potassium. The measurement of serum electrolytes, such as sodium, potassium, and chloride, by indirect ion selective electrode methods in this study was not significantly impacted by lipemia brought on by intralipid spiking; the mean apparent concentrations of sodium, potassium, and chloride in all test serum pools differed by less than 1% from those in the corresponding control serum pools.